Page 134 - 2019食藥署年報(英文版)

5BCMF c "NFOENFOUT PG (VJEFMJOFT BOE 3FHVMBUJPOT GPS UIF 6TF PG /BSDPUJD "OBMHFTJDT JO BCMF
5

Announcement Announcement name Description of the amendment
date
%FDFNCFS $PHQGPHQW WR WKH *XLGHOLQHV DQG ,Q UHVSRQVH WR WKH LPSOHPHQWDWLRQ RI WKH 3DWLHQW 5LJKW WR $XWRQRP\
5HJXODWLRQV IRU &OLQLFLDQV /RQJ $FW WKH $JUHHPHQW IRUP VLJQHG E\ WKH SDWLHQWV ZLWK QRQ FDQFHU
Term FKURQLF LQWUDFWDEOH SDLQ ZKR ORQJ WHUP XVH QDUFRWLF DQDOJHVLFV ZDV
3UHVFULELQJ 1DUFRWLF $QDOJHVLFV 7R UHYLVHG WR ,QIRUPHG &RQVHQW )RUP LQ ZKLFK WKH ZLWQHVV LQ WKH
3DWLHQWV :LWK 1RQ FDQFHU RULJLQDO IRUP ZDV DPHQGHG WR LI WKH SDWLHQW LV LOOLWHUDWH WKH SDWLHQW
&KURQLF ,QWUDFWDEOH 3DLQ FDQ XVH ¿QJHUSULQW LQVWHDG RI VLJQDWXUH DQG WKH LQIRUPDWLRQ RI ZLWQHVV
VKRXOG EH ¿OOHG RXW E\ DQ DGXOW ZLWQHVV WR HQKDQFH WKH SDWLHQW ULJKW
to autonomy.
$PHQGPHQW WR WKH 5HJXODWLRQV IRU ,Q UHVSRQVH WR WKH LPSOHPHQWDWLRQ RI WKH +RVSLFH 3DOOLDWLYH &DUH $FW
7HUPLQDO 3DWLHQW¶V 8VH RI $GGLFWLYH WKH 5HJXODWLRQV IRU WKH 8VH RI 1DUFRWLF $QDOJHVLFV LQ
1DUFRWLF 'UXJV DW +RPH 7HUPLQDO &DQFHU 3DWLHQWV 5HFHLYLQJ +RPH &DUH ZDV DPHQGHG WR WKH
5HJXODWLRQV IRU WKH 8VH RI 1DUFRWLF $QDOJHVLFV LQ 3DWLHQWV 5HFHLYLQJ
(QG RI OLIH +RPH &DUH 7KH IROORZLQJ DUH WKH NH\ SRLQWV
7KH 7HUPLQDO ,OOQHVV 3DWLHQWV ZKR XVH QDUFRWLF DQDOJHVLFV IRU
D ORQJ SHULRG RI WLPH IRU SDLQ WUHDWPHQW DUH QR ORQJHU UHTXLUHG WR
report to the TFDA.
$FFRUGLQJ WR WKH SUHYLRXV 5HJXODWLRQV IRU WKH 8VH RI 1DUFRWLF
$QDOJHVLFV LQ 7HUPLQDO &DQFHU 3DWLHQWV 5HFHLYLQJ +RPH &DUH
the terminal cancer patients need to apply to the TFDA for the
H[WHQVLRQ RI SUHVFULSWLRQ GD\V $IWHU EHLQJ DSSURYHG WKH QXPEHU RI
SUHVFULSWLRQ GD\V IRU RUDO RU WRSLFDO QDUFRWLF GUXJV PD\ EH H[WHQGHG
IRU GD\V RQ WKH EDVLV RI WKH QHZ UHJXODWLRQV WKH KRVSLWDO
&RQWUROOHG 'UXJ 0DQDJHPHQW &RPPLWWHH LV DXWKRUL]HG WR H[WHQG WKH
SUHVFULSWLRQ RI QDUFRWLF DQDOJHVLFV IRU XS WR GD\V GHSHQGLQJ RQ
the needs of patients.
$PHQGPHQW WR WKH *XLGDQFH DQG $GGHG WKH XVH JXLGHOLQH DQG UHYLVHG PDQDJHPHQW UHJXODWLRQV
5HJXODWLRQV IRU WKH 8VH RI $GGLFWLYH
1DUFRWLF $QDOJHVLFV LQ SDWLHQW
&RQWUROOHG $QDOJHVLD 3&$
$PHQGPHQW WR WKH *XLGHOLQHV $GGHG WKH XVH JXLGHOLQH DQG UHYLVHG UHJXODWLRQV UHJDUGLQJ SUHVFULSWLRQ
DQG 5HJXODWLRQV IRU WKH 8VH RI days.
Transdermal Fentanyl Patch For
3DLQ 0DQDJHPHQW
$GGLWLRQDO UHJXODWLRQ RI WKH 7KH JXLGHOLQH IRU WKH XVH RI QDUFRWLF DQDOJHVLFV ZDV DPHQGHG WR
*XLGHOLQHV DQG 5HJXODWLRQV IRU WKUHH SDWLHQW FDWHJRULHV 1RQ FDQFHU 3DWLHQWV &DQFHU SDWLHQWV DQG
WKH 8VH RI 1DUFRWLF $QDOJHVLFV LQ 7HUPLQDO LOOQHVV SDWLHQWV 7KLV UHJXODWLRQ ZDV DGGHG WR EH XVHG IRU
&DQFHU 3DLQ 0DQDJHPHQW clinical reference.
$PHQGHG WKH 5HJXODWLRQV IRU $FFRUGLQJ WR WKH &RQWUROOHG 'UXJV $FW WKH QDUFRWLF GUXJV ZDV
WKH 8VH RI 1DUFRWLF $QDOJHVLFV LQ DPHQGHG WR QDUFRWLF DQDOJHVLFV QDUFRWLF GUXJV PDQDJHU ZDV
+RVSLWDO 6HWWLQJ DPHQGHG WR FRQWUROOHG GUXJ PDQDJHU
$PHQGPHQW WR WKH SURYLVLRQV RI $UWLFOH 3DUDJUDSK LQ WKH
&RQWUROOHG 'UXJV $FW WKH 7KH UHVLGXH RI WKH FRQWUROOHG GUXJV
IURP WKH GLVSHQVLQJ DQG DGPLQLVWHULQJ RI D UHJLVWUDQW VKDOO EH
GHVWUR\HG E\ LWV PDQDJHU DQG UHODWHG SHRSOH DQG UHFRUGV NHSW IRU
future reference. "
$PHQGPHQW WR WKH SURYLVLRQV 7KH RULJLQDO QDPH IRU WKH 5HJXODWLRQV IRU &OLQLFLDQV 3UHVFULELQJ
RI *XLGHOLQHV IRU &OLQLFLDQV Narcotic
3UHVFULELQJ 1DUFRWLF $QDOJHVLFV WR $QDOJHVLFV WR 3DWLHQWV ZLWK 1RQ &DQFHU &KURQLF
3DWLHQWV ZLWK 1RQ &DQFHU &KURQLF ,QWUDFWDEOH 3DLQ $QG 6XVSHFWHG RI 'UXJ $GGLFWLRQ ZDV DPHQGHG DV
,QWUDFWDEOH 3DLQ $QG 6XVSHFWHG RI PRVW RI LWV FRQWHQWV DUH UHODWHG WR FOLQLFDO PDWWHUV DQG WKH 6XEVWDQFH
'UXJ $GGLFWLRQ 8VH 'LVRUGHU ZDV DGGHG WR EH XVHG DV D UHIHUHQFH IRU FOLQLFDO
GLDJQRVLV
132